Intelligent Bio Solutions Secures Eighth European Patent for Volume-Corrected Fingerprint Testing
Intelligent Bio Solutions received European Patent EP3752831, marking its eighth European patent for its fingerprint sweat drug testing technology. The patent protects a method correlating chemical analysis with fingerprint deposition volume, enhancing result interpretation and the robustness of its non-invasive testing process across its European IP portfolio.
1. European Patent Grant
Intelligent Bio Solutions has been granted European Patent EP3752831, its eighth such approval in Europe. This patent specifically covers contextualizing chemical analysis results with the volume of fingerprint residue during sample collection.
2. Technological Advancement
The patented method correlates detected substance levels in fingerprint sweat with deposition volume, improving the interpretation of chemicals and reducing false positives. This innovation bolsters the precision and reliability of the company’s non-invasive drug screening system.
3. Strengthened Market Position
With an expanded European IP portfolio covering lateral flow analysis, cartridges, and test strip readers, the company enhances its barriers to entry. The latest patent reinforces its competitive edge in safety-critical sectors seeking rapid, dignified drug testing.